Abstract:Immunological disorders are one of the main causes of recurrent spontaneous abortions (RSA). A rapidly expanding body of evidence indicates that excessive activation of the complement system is critically involved in the development of miscarriages. In the CBA/J × DBA/2 murine model of recurrent miscarriage, exaggerated and unrestrained complement activation is reported to be the underlying cause of angiogenic factor imbalance and persistent inflammation. We have previously shown that mesenchymal stem cell (MSC) therapy can significantly reduce the abortion rate in abortion-prone mice through regulating the feto-maternal immune response. In the present study, we hypothesized that MSCs might improve the balance of angiogenic factors at the feto-maternal unit of CBA/J × DBA/2 mice by restraining complement activation and deposition. To explore this hypothesis, autologous adipose tissue-derived mesenchymal stem cells (AD-MSCs) were administered intra-peritoneally to abortion-prone mice on the 4.5th day of gestation. Control mice received PBS as vehicle. On day 13.5 of pregnancy, deposition of the complement component C3 and expression levels of Crry, CFD (adipsin), VEGF, PlGF and FLT-1 were measured at the feto-maternal interface by immunohistochemistry and real-time PCR, respectively. Decidual cells were also cultured in RPMI 1640 medium for 48 h and VEGF and sFLT-1 protein levels were quantified in supernatants using enzyme-linked immunosorbent assay (ELISA). Our results indicated that MSC therapy significantly reduced C3 deposition and adipsin transcription in the fetal-maternal interface of abortion-prone mice. Furthermore, administration of MSCs robustly upregulated the mRNA expression levels of Crry, VEGF, PlGF and FLT-1 in the placenta and decidua of CBA/J × DBA/2 mice. Consistently, the in vitro results demonstrated that decidual cells obtained from MSC-treated dams produced increased concentrations of VEGF in culture supernatants, with concomitant decreased levels of sFLT-1 protein. Here, we show for the first time that adoptive transfer of MSCs rectifies the disturbed balance of angiogenic factors observed at the feto-maternal unit of CBA/J × DBA/2 mice, in part at least, through inhibiting excessive complement activation and promoting the production of angiogenic factors. Collectively, these alterations seem to play a pivotal role in reducing the abortion rate and improving the intrauterine condition for the benefit of the fetus.

Mesenchymal stem cells enhance Treg immunosuppressive function at the fetal-maternal interface

Mesenchymal stem cells induce expansion of regulatory T cells in abortion-prone mice

Cell-cell contact with proinflammatory macrophages enhances the immunotherapeutic effect of mesenchymal stem cells in two abortion models

Bone Mesenchymal Stem Cells Improve Pregnancy Outcome by Inducing Maternal Tolerance to the Allogeneic Fetus in Abortion-Prone Matings in Mouse.

Mesenchymal stem cell therapy attenuates complement C3 deposition and improves the delicate equilibrium between angiogenic and anti-angiogenic factors in abortion-prone mice

Immunological effects of human decidual mesenchymal stem cells in spontaneous and recurrent abortions

Impact of regulatory T cell therapy on immune cell composition and fetal survival rate in abortion prone mice

MDSCs interactions with other immune cells and their role in maternal-fetal tolerance

Efficacy of mesenchymal stromal cells in the treatment of unexplained recurrent spontaneous abortion in mice: An analytical and systematic review of meta-analyses

Decidual And Peripheral Blood Tcr Alpha Beta(+)Cd3(+)Cd4(-)Cd8(-) Double Negative Regulatory T Cells In Early Pregnancy Subjects And Unexplained Recurrent Spontaneous Abortion Patients

New insights into myeloid-derived suppressor cells and their roles in feto-maternal immune cross-talk.

Decidual and peripheral blood TCRαβ + CD 3 + CD 4-CD 8-double negative regulatory T cells in early pregnancy subjects and unexplained recurrent spontaneous abortion patients

Anti-inflammatory effects of mesenchymal stem cell-derived exosomal microRNA-146a-5p and microRNA-548e-5p on human trophoblast cells.

Murine model: maternal administration of stem cells for prevention of prematurity

Decidual Vascular Endothelial Cells Promote Maternal–fetal Immune Tolerance by Inducing Regulatory T Cells Through Canonical Notch1 Signaling

MicroRNA-181a regulates local immune balance by inhibiting proliferation and immunosuppressive properties of mesenchymal stem cells.

Embryonic Trophoblasts Induce Decidual Regulatory T Cell Differentiation and Maternal–Fetal Tolerance Through Thymic Stromal Lymphopoietin Instructing Dendritic Cells

Deciphering decidual deficiencies in recurrent spontaneous abortion and the therapeutic potential of mesenchymal stem cells at single-cell resolution

Human Decidua Mesenchymal Stem Cells Regulate Decidual Natural Killer Cell Function Via Interactions Between Collagen and Leukocyte-Associated Immunoglobulin-Like Receptor 1

Myeloid-derived Suppressor Cells Are Essential for Maintaining Feto-Maternal Immunotolerance Via STAT3 Signaling in Mice.

Dendritic Cells Therapy Confers a Protective Microenvironment in Murine Pregnancy